Illumina to Buy Gates, Bezos-Backed Grail in $8 Billion Deal
A technician places a flow cell glass slide into an Illumina Inc. DNA sequencing machine. (Photographer: Anthony Kwan/Bloomberg)

Illumina to Buy Gates, Bezos-Backed Grail in $8 Billion Deal

(Bloomberg) -- Illumina Inc.’s shares fell after the genetic sequencing giant agreed to acquire Grail Inc. in a deal valuing the cancer-detection startup at $8 billion.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.